Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2004

Jan 29, 2004

35134_dirs_2004-01-29_5feeb101-d1f0-48fc-9e38-db203eb8e89e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2003-12-31

Reporting Person: JENSEN JULIAN D (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2003-08-21 Croff Enterprises, Inc. Common Stock J 7642 $1 Acquired 17642 Direct
2003-09-10 Croff Enterprises, Inc. Common Stock J 14021 $1 Acquired 31663 Direct

Footnotes

F1: Acquired by Trust distribution